Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients
NCT ID: NCT07182643
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
90 participants
OBSERVATIONAL
2025-10-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
NCT05339451
Serum and Peritoneal Fluid Bank for Endometriosis Markers
NCT00194233
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885
First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis
NCT07240363
Endometriosis Biomarker Discovery Study
NCT03272360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endometriosis
Moderate/severe endometriosis
Endometrial fluid
Endometrial fluid collection in the day of OPU
Endometrial biopsy
Endometrial biopsy on the OPU day, Pipelle
Follicular fluid
Follicular fluid sampling on the OPU day
Controls
Healthy women undergoing oocyte pick up
Endometrial fluid
Endometrial fluid collection in the day of OPU
Endometrial biopsy
Endometrial biopsy on the OPU day, Pipelle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endometrial fluid
Endometrial fluid collection in the day of OPU
Endometrial biopsy
Endometrial biopsy on the OPU day, Pipelle
Follicular fluid
Follicular fluid sampling on the OPU day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with moderate/severe endometriosis by ultrasound or laparoscopy (patient group)
* Regular menstrual cycles 28-35 days
* Speak English or Swedish and agree to participate in the study
Exclusion Criteria
* Uterine anomalies
* Pelvic inflammatory disease, endometritis, STD
* Gynaecological cancers or other malignancies in the patient's history
* Smoking (more than 10 cigarettes per day) or alcohol abuse
* Immunosuppressing medicines
* Major abdominal or pelvic surgery in the last 3 months
* A specific genetic disease that is diagnosed before PGT in women undergoing treatment
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenny Rodriguez-Wallberg, Professor
Role: PRINCIPAL_INVESTIGATOR
Onk/Pat Karolinska Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institute and Karolinska University Hospital Huddinge
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-03224-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.